SLU-PP-332 5mg

SLU-PP-332 is a small-molecule selective pan-agonist of the oestrogen-related receptors (ERRα, ERRβ and ERRγ), orphan nuclear receptors that regulate mitochondrial biogenesis, oxidative metabolism and skeletal muscle endurance programmes. By engaging all three ERR subtypes it has emerged as a leading exercise-mimetic research tool for interrogating metabolic adaptation and oxidative capacity. The 5mg presentation supports pilot characterisation work.

Supplied as a lyophilised research compound for reconstitution in an appropriate vehicle prior to assay use. The 5mg loading suits pilot dose-finding, receptor activation profiling and small-cohort metabolic studies where conservative material use is preferred.

Research Applications • ERRα, ERRβ and ERRγ nuclear receptor activation and selectivity profiling • Mitochondrial biogenesis and oxidative phosphorylation gene expression studies • Exercise-mimetic and skeletal muscle endurance adaptation investigation • Metabolic and energy expenditure research in cell and animal models

Specification • Identity: SLU-PP-332 (CAS 2138861-99-9) • Molecular weight: 426.51 g/mol • Purity: 99%+ verified by HPLC and Mass Spectrometry • Format: lyophilised research compound — reconstitute in an appropriate vehicle before use • Storage: store lyophilised at -20°C; once reconstituted, refrigerate at 2-8°C and use within 4-6 weeks; protect from light

For research use only — not for human consumption.